FDA official logo
GSRS logoPFDA official logo

MIRVETUXIMAB SORAVTANSINE

UNII:98DE7VN88D
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:MIRVETUXIMAB SORAVTANSINE
GSRS Full Record:
98DE7VN88D
i

  • 1453084-37-1
  • ELAHERE
  • IMGN-853
  • IMGN853
  • Immunoglobulin G1, anti-(human folate receptor α) (human-Mus musculus monoclonal M9346A heavy chain), disulfide with human-Mus musculus monoclonal M9346A light chain, dimer, tetraamide with N2'-[4-[(3-carboxy-3- sulfopropyl)dithio]-4-methyl-1-oxopentyl]-N2'-deacetylmaytansine
  • Immunoglobulin G1-kappa, anti-(human folate receptor alpha (adult folatebending protein, folate receptor 1, KB cells FBP, ovarian tumor-associated antigen Mov18)); humanized mouse monoclonal antibody linked to an average of four molecules of maytansine acid derivative : amide between an average of four molecules of (2RS,12S)-14-[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11- chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24- dioxa-9,22-diazatetracyclo[19.3.1.110.14.03.5]hexacosa-10,12,14(26),16,18- pentaen-6-yl]-7,7,11,12-tetramethyl-10,13-dioxo-2-sulfonyl-14-oxa-5,6-dithia11-azatetradecanoic acid and an average of four amino groups of γ1 heavy chain (1-447) [Mus musculus VH (IGHV1-37*01–(IGHD)-IGHJ4*01) (88%) [8.8.11] (1-119) –des-(CH3K107 (448))-IGHG1*01 (119-447)] (221-218')- disulfide with kappa light chain (1'-218') [Mus musculus V-KAPPA (IGKV3-9*01-IGKJ1*02) (81%) [10.3.9] (1'-111') -IGKC*01 (112'-218')] dimer (227-227'':230-230'')-bisdisulfide
  • MIRVETUXIMAB SORAVTANSINE [USAN]
  • Mirvetuximab Soravtansine
  • Mirvetuximab Soravtansine-GYNX
  • Mirvetuximab soravtansine [MI]
  • Mirvetuximab soravtansine [WHO-DD]
  • Mirvetuximab soravtansine gynx [WHO-DD]
  • mirvetuximab soravtansine [INN]




UNII - 98DE7VN88D | UNII Search Service